Expression of respiratory mucins in fatal status asthmaticus and mild asthma

Histopathology

Volumn 40, Issue 4, 2002, Pages 367-373

  Groneberg, D A ^a   Eynott, P R ^a   Lim, S ^a   Oates, T ^a   Wu, R ^b   Carlstedt, I ^c   Roberts, P ^e   McCann, B ^e   Nicholson, A G ^d   Harrison, B D ^e   Chung, K F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LUND UNIVERSITY   (Sweden)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

Author keywords

Asthma; Autopsy; Biopsy; Immunohistochemistry; Lung; Mucins

Indexed keywords

BUDESONIDE; CORTICOSTEROID; MONOCLONAL ANTIBODY; MUCIN; MUCIN 5AC; MUCIN 5B; SALBUTAMOL; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; ASTHMATIC STATE; BRONCHUS BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GOBLET CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MUCUS SECRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ASTHMA; HUMANS; IMMUNOHISTOCHEMISTRY; MUCINS; PROTEIN ISOFORMS; RESPIRATORY MUCOSA; SEVERITY OF ILLNESS INDEX;

BRONCHUS;

EID: 0036268342     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.01378.x     Document Type: Article

References (33)

1. Pathophysiology of asthma
2. Monitoring the patient with asthma: An evidence-based approach
3. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack
4. Analysis of respiratory mucus glycoproteins in asthma: A detailed study from a patient who died in status asthmaticus
5. Airway inflammation and remodeling in asthma
6. Mucus glycoproteins from 'normal' human tracheobronchial secretion
7. Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'
8. The structure of tracheobronchial mucins from cystic fibrosis and control patients
9. Mucins in airway secretions from healthy and chronic bronchitic subjects
10. Epithelial mucin genes
11. MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways
12. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: Identification of glycoforms and C-terminal cleavage
13. MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions
14. Localization and up-regulation of mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis
15. Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions
16. Respiratory mucins: Identification of core proteins and glycoforms
17. Identification of two glycoforms of the MUC5B mucin in human respiratory mucus. Evidence for a cysteine-rich sequence repeated within the molecule
18. Control of mucin transcription by diverse injury-induced signaling pathways
19. Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression
20. Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: Effect of inhaled corticosteroids
21. Different mucins are produced by the surface epithelium and the submucosa in human trachea: Identification of MUC5AC as a major mucin from the goblet cells
22. Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects
23. Small airways disease
24. Muscle and mucous gland size in the major bronchi of patients with chronic bronchitis, asthma, and asthmatic bronchitis
25. Application of density gradient methods for the study of mucus glycoprotein and other macromolecular components of the sol and gel phases of asthmatic sputa
26. Characterization of airway mucus from a fatal case of status asthmaticus
27. Physical characterization of the MUC5AC mucin: A highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions
28. Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug
29. Structural alterations and inflammation of bronchi in asthma
30. The effects of corticosteroids on mucous glycoprotein secretion from human airways in vitro
31. Dexamethasone suppresses mucus production and MUC-2 and MUC-5AC gene expression by NCI-H292 cells
32. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
33. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma